Mucosal Fixed Drug Eruption to Levetiracetam with Early Positive Patch
Test on Non-Lesional Skin
Abstract
Levetiracetam (LEV) is a second-generation antiepileptic drug (AED) that
is well tolerated, has a broad spectrum of action, low protein binding,
and minimal hepatic metabolism. The incidence of hypersensitivity to LEV
in children and adults is 0.6%. This is the first reported fixed drug
eruption (FDE) identified using a patch test in a pediatric case
associated with LEV